Spark Investment Management LLC Esperion Therapeutics, Inc. Transaction History

Spark Investment Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$30.04 - $51.31 $303,404 - $518,231	-10,100 Closed	0 $0
Q4 2019 Feb 11, 2020	SELL	$35.4 - $59.82 $1.94 Million - $3.28 Million	-54,800 Reduced 84.44%	10,100 $602,000
Q3 2019 Nov 12, 2019	SELL	$34.47 - $47.53 $6.54 Million - $9.02 Million	-189,800 Reduced 74.52%	64,900 $2.38 Million
Q2 2019 Aug 12, 2019	SELL	$40.1 - $52.33 $5.46 Million - $7.13 Million	-136,200 Reduced 34.84%	254,700 $11.8 Million
Q1 2019 May 07, 2019	BUY	$40.11 - $53.57 $6.57 Million - $8.77 Million	163,800 Added 72.13%	390,900 $15.7 Million
Q4 2018 Feb 12, 2019	BUY	$36.99 - $59.11 $3.81 Million - $6.09 Million	103,100 Added 83.15%	227,100 $10.4 Million
Q3 2018 Nov 13, 2018	BUY	$40.74 - $51.41 $1.77 Million - $2.23 Million	43,400 Added 53.85%	124,000 $5.5 Million
Q2 2018 Aug 08, 2018	BUY	$36.2 - $76.4 $1.35 Million - $2.84 Million	37,200 Added 85.71%	80,600 $3.16 Million
Q1 2018 May 10, 2018	BUY	$65.94 - $80.76 $2.86 Million - $3.5 Million	43,400 New	43,400 $3.14 Million

207

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $164M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Spark Investment Management LLC with notifications on news.